TrialsgrambetaRCTs are beautiful

Cappato IST

2012

Clinical Efficacy of Ivabradine in Patients with Inappropriate Sinus Tachycardia

In 21 patients with symptomatic inappropriate sinus tachycardia, ivabradine eliminated most symptoms and lowered heart rate at rest, on standing and during exertion compared with placebo.

Result

Efficacy: Elimination of symptoms attributable to inappropriate sinus tachycardiarelative risk 0.25 (95% CI 0.18-0.34) · P < 0.001

Below 1 favours ivabradine, above 1 favours placebo.

Also reported: With complete elimination in 47 %. Resting heart rate fell from 88 to 76 bpm (p=0.011).

Original publication
Subtopic
Inappropriate sinus tachycardia
Design
Double-blind, placebo-controlled crossover RCT
Relevance
Supporting: context rather than must-know.
Source
Cappato R, Castelvecchio S, Ricci C, et al. J Am Coll Cardiol. 2012;60(15):1323-1329.doi 10.1016/j.jacc.2012.06.031

Discussion & critique

Very small, single-centre and short, with a subjective primary endpoint and no beta-blocker comparator: a proof of concept rather than a definitive trial. It is nevertheless the only randomised placebo-controlled evidence in inappropriate sinus tachycardia and is the entire basis of the ivabradine recommendation.